Micro Medical Solutions Receives FDA IDE Approval for Pivotal Clinical Trial of MicroStent - Cath Lab Digest

Micro Medical Solutions Receives FDA IDE Approval for Pivotal Clinical Trial of MicroStent  Cath Lab Digest

Clinical investigators will study the safety and efficacy of this microvascular device designed to restore blood flow and reduce amputations resulting from ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more